Cardiology Flashcards
BHAT
Propranolol after acute myocardial infarction
CLARITY trial
Adding clopidogrel to STEMI management
MIRACL trial
Atorvastatin reduces recurrent ischemia post-ACS
PLATO trial
Ticagrelor superior to clopidogrel for ACS
TNT trial
Intensive statin therapy in coronary heart disease
PROVE IT trial
High-dose statin regimen reduces mortality
CURE trial
Clopidogrel reduces death from CV disease in ACS without ST-elevation
CARE trial
Statins in coronary artery disease
SAVE trial
Captopril after acute MI reduces mortality and morbidity
RALES trial
Spironolactone decreases all-cause mortality in heart failure patients
HOPE trial
Ramipril significantly reduces cardiovascular events in high-risk patients with normal ejection fractions
CONSENSUS
Enalapril reduces mortality in severe heart failure
EPHESUS trial
Eplerenone in heart failure after MI
DOSE trial
Loop diuretic strategies in acute decompensated
CHARM-Alternative trial
Angiotensin-receptor blockers in HF
ATLAS trial
high dose ACE inhibitor dosing in chronic HF
PARADIGM-HF trial
Valsartan-neprilysin inhibitor vs. enalapril in patients with heart failurePARADIGM-HF trial: Valsartan-neprilysin inhibitor vs. enalapril in patients with heart failure
ACTIVE trial
Dual antiplatelet therapy in afib
RACE-II trial
Lenient non-inferior to strict rate-control in afib & less medication needed
SPAF trial
Warfarin and aspirin reduce the risk of stroke in atrial fibrillation
ROCKET AF
Rivaroxaban non-inferior to warfarin and lower incident of bleeding in AF
HAS-BLED score
Bleeding risk in atrial fibrillation
AFFIRM trial
Rate-control main approach vs. rhythm-control in atrial fibrillation (less adverse events no difference mortality)
DASH trial
Diet change significantly reduces blood pressure (rich in fruits and vegetables and low in saturated and total fat)
SPRINT
Intensive (120) better than standard (140) blood pressure control in pts w/ HTN and CV risk
Lee index
Risk of perioperative cardiac events
Wells DVT criteria
Clinical prediction model for deep vein thrombosis
CARESS trial
Dual antiplatelet therapy superior to monotherapy in symptomatic carotid stenosis w/o increase risk of bleeding